Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect Study of ABN401 in Healthy Volunteers
NCT05248074Phase 1Completed
- Sponsor
- ABION Inc.
- Start
- Jan 2022
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vabametkib in solid tumor (2 arms), sponsored by ABION Inc. Primary endpoints: Area Under the Curve from time 0 to the last measurable concentration at 24 hours and Maximum Observed Plasma Concentration at 24 hours. Started Jan 2022; status: completed.
02
Drugs
vabametkib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05248074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05248074.